Approval · Notice of Compliance 5718 · 1994
PROHANCE: Notice of Compliance 5718
Issued March 16, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5718
- Date
- March 16, 1994
- Company
- Squibb Diagnostics Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New source of finished product
- Therapeutic class
- Contrast enhancement preparation for magnetic resonance imaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROHANCE | Not yet assigned | — |
Medicinal ingredients
- GADOTERIDOL 279.3 MG per ML